[1] Chinese Thoracic Society, Chinese Medical Association.Guidelines for Bronchial Asthma Prevent and Management(2024 Edition)[J]. Chinese Journal of Tuberculosis and Respiratory Diseases(中华结核和呼吸杂志), 2025, 48(3): 208-248. [2] Occupational Lung Disease Group of Labor Hygiene and Occupational Diseases Branch of Chinese Preventive Medicine Association. Consensus of Chinese Experts on Pneumoconiosis Treatment (2024)[J]. Journal of Environmental and Occupational Medicine(环境与职业医学), 2024, 41(1): 1-21. [3] LI XT, ZHAI SD, WANG Q, et al.Recommendations in Guideline for Emergency Management of Anaphylaxis[J]. ADRJ(药物不良反应杂志), 2019, 21(2): 85-91. [4] WANG SP, YU HP, QIAO YP.One Case of Anaphylactic Shock Induced by Intravenous Injection of Diprophylline[J]. Ningxia Medical Journal(宁夏医学杂志), 2003, 25(6): 348. [5] ZHI CF, SHI SQ, YUAN SF, et al.Clinical Medication Analysis of One Case of Palpitations Induced by the Combination of Diprophylline and Levofloxacin[J]. Journal of Baotou Medicine(包头医学), 2023, 47(1): 61. [6] PING XQ, WANG TJ, LI LB.One Case of Sudden Cardiac Death Caused by Combined Use of Cefoperazone and Sulbactam Sodium and Diprophylline[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2012, 9(4): 254. [7] LENG LL, ZHENG XL.One Case of Acute Delirium Induced by Diprophylline Injection[J]. The Medical Forum(基层医学论坛), 2023, 27(22): 144-147. [8] WU N, LI B, YU S, et al.Epidermolysis Bullosa Induced by Dyphylline for Injection: One Case Report[J]. Chinese Journal of Hospital Pharmacy(中国药物警戒), 2022, 42(17): 1847-1849. [9] SUN T, XU XQ, LIU L.An Analysis of 35 Cases of Adverse Reactions Induced by Diprophylline[J]. Chinese Journal of Drug Abuse Prevention and Treatment(中国药物滥用防治杂志), 2025, 31(1): 32-34, 50. [10] XIAO Q.Observation of Clinical Efficacy and Adverse Reactions of Diprophyllinein the Treatment of Chronic Obstructive Pulmonary Disease[J]. Journal of Medical Information(医学信息), 2024, 37(15): 130-133. [11] Dyphylline. In: Drugs and Lactation Database (LactMed®)[Internet] [M/OL]. Bethesda (MD): National Institute of Child Health and Human Development, (2006)[2025-11-15]. https://www.ncbi.nlm.nih.gov/books/NBK501476/. [12] NMPA. Announcement of the National Medical Products Administration on Issuing the Directory of Reference Listed Drugs for Generic Drugs (Batch 47)(No.83,2021)[EB/OL]. (2021-10-20)[2025-11-10]. https://www.nmpa.gov.cn/yaopin/ypggtg/20211020172152152.html. [13] PMDA. Pharmaceuticals and Medical Devices Agency. Package Insert of Diprophylline Injection[EB/OL]. (2021-03-31)[2025-11-10].https://www.pmda.go.jp/PmdaSearch/iyakuDetail/GeneralList/2115401. [14] XIAO HL.New Safety Evaluation of Dextrans as Pharmaceutical Excipients by EMA[J]. Drug Evaluation Research(药物评价研究), 2019, 42(6): 1069-1074. [15] ZHANG T, WU Q, WANG J, et al.Clinical Safety Risks of the Injections Containing the Pharmaceutical Excipient Dextran 40[J]. ADRJ(药物不良反应杂志), 2024, 26(4): 234-237. [16] NMPA. Announcement of the State Drug Administration on Revision of Diprophylline Injection(No.82, 2024)[EB/OL]. (2024-07-03)[2025-11-10]. https://www.nmpa.gov.cn/xxgk/ggtg/ypggtg/ypshmshxdgg/20240703152343185.html. [17] ZHANG PP.Survey and Analysis on the Use of High-Alert Medications in the Affiliated Children’s Hospital of a Certain Hospital[J]. Journal of China Prescription Drug(中国处方药), 2022, 20(7): 26-27. |